A6043812
4-(5-Methyl-3-phenylisoxazol-4-yl)benzenesulfonic acid , 98% , 181696-35-5
| Pack Size | Price | Stock | Quantity |
| 25MG | RMB103.20 | In Stock |
|
| 100MG | RMB293.60 | In Stock |
|
| 250mg | RMB398.40 | In Stock |
|
| 1g | RMB916.80 | In Stock |
|
| 5g | RMB3722.40 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | >88°C (dec.) |
| Density | 1.341±0.06 g/cm3(Predicted) |
| storage temp. | Sealed in dry,Room Temperature |
| solubility | Acetone (Slightly), DMSO (Slightly), Ethyl Acetate (Slightly), Methanol (Slightly) |
| pka | -0.92±0.50(Predicted) |
| form | Solid |
| color | White to Off-White |
| InChI | InChI=1S/C16H13NO4S/c1-11-15(12-7-9-14(10-8-12)22(18,19)20)16(17-21-11)13-5-3-2-4-6-13/h2-10H,1H3,(H,18,19,20) |
| InChIKey | LLWOSCPRJRUVST-UHFFFAOYSA-N |
| SMILES | C1(S(O)(=O)=O)=CC=C(C2=C(C)ON=C2C2=CC=CC=C2)C=C1 |
Description and Uses
Valdecoxib Sulfonic Acid is a metabolite of the potent and specific inhibitor of cyclooxygenase-2, Valdecoxib (V090000).
Safety
| Symbol(GHS) |  GHS07 |
| Signal word | Warning |
| Hazard statements | H302-H315-H319-H335 |
| Precautionary statements | P261-P305+P351+P338 |
